International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ observations were conducted at the Ersa site (northern tip of Corsica; 533 m a.s.l.) to characterise the optical, physical and chemical properties of aerosols. During the observation period, a major influence of primary marine aerosols was detected (22-26 June), with a mass concentration reaching up to 6.5 µg m −3 and representing more than 40 % of the total PM 10 mass concentration. Its relatively low ratio of chloride to sodium (average of 0.57) indicates a fairly aged sea salt aerosol at Ersa. In this work, an original data set, obtained from online real-time instruments (ATOFMS, PILS-IC) has been used to charac-terise the ageing of primary ...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...
International audienceAs part of the ChArMEx-ADRIMED campaign (summer 2013), ground-based in situ ob...